ArticleCell death discovery2024

Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies.

Sanjeev Raghuwanshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.